Clinical Trial Update: A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of gefitinib, trametinib, disulfiram, and sunitinib with standard chemotherapy for osteosarcoma; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Disulfiram (Disulfiram)
• Gefitinib (Gefitinib)
• Sunitinib (sunitinib)
• Trametinib (trametinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Osteosarcoma, Metastasis | Phase 2 | Status: RECRUITING